Cipher Pharmaceuticals Inc. (TSX:CPH) will look for acquisitions. Bryan Jacobs, Chief Financial Officer said, "In third quarter, we continued to enhance our liquidity, ending the quarter with a cash balance of $27.5 million, placing us in an excellent position to drive organic growth and fund our development pipeline as well as evaluate profitable product and company acquisitions to accelerate growth and drive shareholder value".